| Literature DB >> 32497396 |
R S Pawar1, S Sagi1, D Leontyev1.
Abstract
Citrus aurantium, commonly known as bitter orange, is a popular dietary supplement ingredient sold worldwide. Bitter orange supplements are sold primarily as weight management and sports performance products and gained popularity after Ephedra products were banned from the US market. Supplements containing synephrine are reported to exhibit adverse cardiovascular effects especially in the presence of caffeine. In this study, an LC-MS/MS method was established to quantify five natural amines (synephrine, octopamine, hordenine, tyramine and N-methyltyramine) and four synthetic amines (phenylephrine, methylsynephrine, etilefrine and isopropyloctopamine) in dietary supplements sold in the US. The method was validated and found to have acceptable performance to accurately measure analytes in complex botanical products. The average recoveries from a blank matrix were between 88 - 125% with an RSD of 0.5 - 7.0%. Fifty-nine products labeled to contain bitter orange peel, extract, or its amines were purchased and their amine content was measured. Several products were found to contain higher amounts of amines than what is expected from a typical bitter orange extract. Out of the 23 products which made label claims for synephrine, only 22% were accurately labeled for their synephrine content. The presence of synthetic amines, methylsynephrine (up to 240 mg/daily serving) and isopropyloctopamine (up to 76 mg/daily serving), whose effects in humans are not known, were detected in six products and one product, respectively. While the use of methylsynephrine and isopropyloctopamine are not permitted in dietary supplements, hordenine, N-methyltyramine and octopamine are currently listed on the FDA's Dietary Supplement Ingredient Advisory List. This article is protected by copyright. All rights reserved.Entities:
Keywords: Bitter orange; adulteration; dietary supplements; phenethylamine; synephrine
Year: 2020 PMID: 32497396 DOI: 10.1002/dta.2871
Source DB: PubMed Journal: Drug Test Anal ISSN: 1942-7603 Impact factor: 3.345